'Another storm coming': WHO warns

Omicron has been detected in at least 38 of the WHO European region's 53 members

The World Health Organization's top official in Europe urged governments on Tuesday to prepare for a significant surge in coronavirus cases across the continent due to the omicron variant, which is already dominant in several countries.

We can see another storm coming, WHO Europe regional director Dr. Hans Kluge said at a press conference in Vienna.

Track the coronavirus footprint across the world here

Within weeks, omicron will dominate in more countries of the region, pushing already stretched health systems further to the brink.

Omicron has been detected in at least 38 of the WHO European region's 53 members, Kluge added, noting that it is already the dominant variant in the United Kingdom, Denmark, and Portugal.

Last week, 27,000 people died from coronavirus in the region and an additional 2.6 million cases were reported, Kluge said.

Although these cases include all variants, not just omicron, he noted this figure is 40 percent higher than during the same period last year.

The sheer volume of new COVID-19 infections could lead to more hospitalizations and widespread disruption to health systems and other critical services, he said.

Thus far, Kluge said 89 per cent of those with confirmed omicron infections in Europe reported symptoms common with other coronavirus variants, including cough, sore throat, fever. The variant has mostly been spread by young people in their 20s and 30s in the region, he added.

Although much remains unknown about omicron, Kluge said it appears to be more infectious than previous variants, leading to previously unseen transmission rates in countries with a significant number of omicron cases. In those countries, cases of the variant are doubling every 1.5 to 3 days.

European governments should keep ramping up their vaccination campaigns, introduce additional measures to slow the spread of the variant, and prepare critical infrastructure like health care systems for the coming surge, Kluge said.

Comments

Post a Comment

Popular posts from this blog

Govt panel recommends EUA for Covovax, Corbevax, Covid pill molnupiravir

Image
An expert panel of the country's central drug authority has recommended granting emergency use authorisation to SII's Covid-19 vaccine Covovax and Biological E's vaccine Corbevax An expert panel of the country's central drug authority has recommended granting emergency use authorisation to Serum Institute of India's COVID-19 vaccine Covovax and Biological E's vaccine Corbevax with certain conditions, official sources said on Monday. The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) on Monday also recommended granting permission to manufacture and market anti-Covid pill Molnupiravir for restricted emergency use for treatment of adult patients with SpO2 93 per cent and who have high risk of progression of the disease, including hospitalisation or death, subject to certain conditions. All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. The SEC on COVID-19
Read more

Karnataka to jab 310,000 in 15-18 age group, 1.2 mn elders from Jan 3

Image
The Karnataka government has identified 31 lakh beneficiaries in the 15 to 18 age group for the first dose of vaccination and 12 lakh elderly people above the age of 60 years The Karnataka government has identified 31 lakh beneficiaries in the 15 to 18 age group for the first dose of vaccination and 12 lakh elderly people above the age of 60 years with comorbidities across the state for a booster dose. Sources in the health department stated that till date, the state government has vaccinated 76 per cent of the targeted population against Covid. Though jabbing 100 per cent beneficiaries still remains a top priority, the vaccination drive for 15 to 18 years will also be focused as this age segment has not received a single shot of Covid vaccine. The initiative will be taken with missionary zeal in the wake of fears of the Omicron variant and the third wave of Covid. The health department officials maintained that the number of elders might be more and they will also be covered when the
Read more

SARS-CoV-2 can damage heart blood vessels without infecting them

Image
The SARS-CoV-2 virus may contribute to the damage of small blood vessels in the heart as seen in severely-ill Covid-19 patients, without infecting them, a study shows. The research, published in the journal Clinical Science, indicates blocking antibodies could represent a new treatment to alleviate cardiovascular complications. A multidisciplinary research team led by the University of Bristol, UK, analysed how SARS-CoV-2 interacts with heart cells causing the myocardial damage seen in COVID-19 patients. Until now, it remained unclear whether heart cells are infected by the virus or damaged because of an excess cytotoxic defence response.   This response, also known as the cytokine storm', comes from our immune cells, whereby cytotoxic cells attack and kill the infected cells by releasing proteins, called cytokines. The study also investigated whether heart cells contribute to producing excess cytokines. The team led by Professor Paolo Madeddu exposed human heart pericytes, which a
Read more